Single User License
INR 170050
Site License
INR 340100
Corporate User License
INR 510150

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Reflux Esophagitis Gastroesophageal Reflux Disease Global Clinical Trials Review, H1

Reflux Esophagitis Gastroesophageal Reflux Disease Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Reflux Esophagitis (Gastroesophageal Reflux Disease) Global Clinical Trials Review, H1, 2015" provides an overview of Reflux Esophagitis (Gastroesophageal Reflux Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Reflux Esophagitis (Gastroesophageal Reflux Disease) . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 7

Reflux Esophagitis (Gastroesophageal Reflux Disease) 7

Report Guidance 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials 16

Clinical Trials by Phase in G7 Countries 17

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials 19

Clinical Trials by Phase in E7 Countries 20

Clinical Trials in E7 Countries by Trial Status 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Clinical Trials by End Point Status 25

Unaccomplished Trials of Reflux Esophagitis (Gastroesophageal Reflux Disease) 26

Subjects Recruited Over a Period of Time 31

Clinical Trials by Sponsor Type 32

Prominent Sponsors 33

Top Companies Participating in Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials 34

Prominent Drugs 35

Clinical Trial Profiles 36

Clinical Trial Overview of Top Companies 36

AstraZeneca Plc 36

Clinical Trial Overview of AstraZeneca Plc 36

Takeda Pharmaceutical Company Limited 43

Clinical Trial Overview of Takeda Pharmaceutical Company Limited 43

Eisai Co., Ltd. 48

Clinical Trial Overview of Eisai Co., Ltd. 48

Johnson & Johnson 51

Clinical Trial Overview of Johnson & Johnson 51

Janssen Global Services, LLC 53

Clinical Trial Overview of Janssen Global Services, LLC 53

Indivior Plc 55

Clinical Trial Overview of Indivior Plc 55

Pfizer Inc. 57

Clinical Trial Overview of Pfizer Inc. 57

Novartis AG 58

Clinical Trial Overview of Novartis AG 58

Yuhan Corporation 59

Clinical Trial Overview of Yuhan Corporation 59

Dr. Reddy's Laboratories Limited 60

Clinical Trial Overview of Dr. Reddy's Laboratories Limited 60

Clinical Trial Overview of Top Institutes / Government 61

Shimane University 61

Clinical Trial Overview of Shimane University 61

Mayo Clinic 62

Clinical Trial Overview of Mayo Clinic 62

Academic Medical Center 63

Clinical Trial Overview of Academic Medical Center 63

Juntendo University School of Medicine 64

Clinical Trial Overview of Juntendo University School of Medicine 64

Seoul National University Hospital 65

Clinical Trial Overview of Seoul National University Hospital 65

Yokohama City University 66

Clinical Trial Overview of Yokohama City University 66

General Public Hospital Zell am See 67

Clinical Trial Overview of General Public Hospital Zell am See 67

Guy's and St Thomas' NHS Foundation Trust 68

Clinical Trial Overview of Guy's and St Thomas' NHS Foundation Trust 68

Hospital Authority 69

Clinical Trial Overview of Hospital Authority 69

National Taiwan University Hospital 70

Clinical Trial Overview of National Taiwan University Hospital 70

Five Key Clinical Profiles 71

Appendix 102

Abbreviations 102

Definitions 102

Research Methodology 103

Secondary Research 103

About GlobalData 104

Contact Us 104

Disclaimer 104

Source 105

List of Figures

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Region (%), 2015* 8

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 11

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 12

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 13

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 14

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 15

Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 16

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18

Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 19

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 22

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 23

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 31

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 32

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 33

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 34

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35

GlobalData Methodology 103

List of Tables

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Region, 2015* 8

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 11

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 12

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, North America, Top Countries, 2015* 13

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 14

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 15

Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 16

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18

Proportion of Reflux Esophagitis (Gastroesophageal Reflux Disease) to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 19

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Phase, 2015* 22

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 23

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Suspended Clinical Trials, 2015* 26

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics, Global, Terminated Clinical Trials, 2015* 28

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 31

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 32

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 33

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 34

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 35

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 36

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 43

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 48

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 51

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2015* 53

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Indivior Plc, 2015* 55

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 57

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 58

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yuhan Corporation, 2015* 59

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2015* 60

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shimane University, 2015* 61

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 62

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 63

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015* 64

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 65

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2015* 66

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by General Public Hospital Zell am See, 2015* 67

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Guy's and St Thomas' NHS Foundation Trust, 2015* 68

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Authority, 2015* 69

Reflux Esophagitis (Gastroesophageal Reflux Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2015* 70

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

AstraZeneca Plc

Takeda Pharmaceutical Company Limited

Eisai Co., Ltd.

Johnson & Johnson

Janssen Global Services, LLC

Indivior Plc

Pfizer Inc.

Novartis AG

Yuhan Corporation

Dr. Reddy's Laboratories Limited

Reflux Esophagitis (Gastroesophageal Reflux Disease) Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Reflux Esophagitis (Gastroesophageal Reflux Disease), Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com